These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3225759)

  • 1. Unsaturated cyclic ureas as new nontoxic biodegradable transdermal penetration enhancers I: Synthesis.
    Wong O; Huntington J; Konishi R; Rytting JH; Higuchi T
    J Pharm Sci; 1988 Nov; 77(11):967-71. PubMed ID: 3225759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chiral 4-
    Chu T; Wang C; Wang J; Wang H; Geng D; Wu C; Zhao L; Zhao L
    Drug Deliv; 2020 Dec; 27(1):723-735. PubMed ID: 32397753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of alkyl-substituted pyrrolidone derivatives and their evaluation as transdermal penetration enhancers.
    Aoyagi T; Yamamura M; Suzuki N; Matsui K; Nagase Y
    Drug Des Discov; 1991 Nov; 8(1):37-46. PubMed ID: 1810410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of fatty acids as skin penetration enhancers-a review.
    Mittal A; Sara UV; Ali A; Aqil M
    Curr Drug Deliv; 2009 Jul; 6(3):274-9. PubMed ID: 19604141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration enhancers.
    Williams AC; Barry BW
    Adv Drug Deliv Rev; 2004 Mar; 56(5):603-18. PubMed ID: 15019749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparations of cyclic sulfoxide derivatives and their evaluation as transdermal penetration enhancers.
    Aoyagi T; Yamamura M; Matsui K; Nagase Y
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1961-3. PubMed ID: 1394720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of 5, 9-dimethyl-2-cyclopropyl-2-decanol as a penetration enhancer for drugs through rat skin.
    Khan GM; Hussain A; Hanif RM
    Pak J Pharm Sci; 2011 Oct; 24(4):451-7. PubMed ID: 21959804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the activity of 2-substituted alkyl-6-(2,5-dioxopyrrolidin-1-yl)hexanoates as skin penetration enhancers.
    Brychtova K; Opatrilova R; Raich I; Kalinowski DS; Dvorakova L; Placek L; Csollei J; Richardson DR; Jampilek J
    Bioorg Med Chem; 2010 Dec; 18(24):8556-65. PubMed ID: 21055950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and transdermal permeation-enhancing activity of carbonate and carbamate analogs of Transkarbam 12.
    Holas T; Vávrová K; Síma M; Klimentová J; Hrabálek A
    Bioorg Med Chem; 2006 Dec; 14(23):7671-80. PubMed ID: 16942882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, physico-chemical properties and penetration activity of alkyl-6-(2,5-dioxopyrrolidin-1-yl)-2-(2-oxopyrrolidin-1-yl)hexanoates as potential transdermal penetration enhancers.
    Brychtova K; Jampilek J; Opatrilova R; Raich I; Farsa O; Csollei J
    Bioorg Med Chem; 2010 Jan; 18(1):73-9. PubMed ID: 19954983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride.
    Mutalik S; Parekh HS; Davies NM; Udupa N
    Drug Deliv; 2009 Feb; 16(2):82-91. PubMed ID: 19267299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin metabolism in transdermal therapeutic systems.
    Hikima T; Tojo K; Maibach HI
    Skin Pharmacol Physiol; 2005; 18(4):153-9. PubMed ID: 15908755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical enhancers for transdermal drug transport.
    Bauerová K; Matusová D; Kassai Z
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):85-94. PubMed ID: 11554439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of discriminant analysis and Machine Learning methods as tools to identify and classify compounds with potential as transdermal enhancers.
    Moss GP; Shah AJ; Adams RG; Davey N; Wilkinson SC; Pugh WJ; Sun Y
    Eur J Pharm Sci; 2012 Jan; 45(1-2):116-27. PubMed ID: 22101136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchrotron FT-IR microscopic study of chemical enhancers in transdermal drug delivery: example of fatty acids.
    Cotte M; Dumas P; Besnard M; Tchoreloff P; Walter P
    J Control Release; 2004 Jun; 97(2):269-81. PubMed ID: 15196754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azone analogues: classification, design, and transdermal penetration principles.
    Jampilek J; Brychtova K
    Med Res Rev; 2012 Sep; 32(5):907-47. PubMed ID: 22886628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination strategies for enhancing transdermal absorption of sumatriptan through skin.
    Femenía-Font A; Balaguer-Fernández C; Merino V; López-Castellano A
    Int J Pharm; 2006 Oct; 323(1-2):125-30. PubMed ID: 16809010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of different penetration enhancers on diclofenac permeation across horse skin.
    Ferrante M; Andreeta A; Landoni MF
    Vet J; 2010 Dec; 186(3):312-5. PubMed ID: 19815433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.